Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Radiotherapy

 

IVBAR spreads its wings

For-profit healthcare data platform the IVBAR Institute, which works for both payors and operators to analyse patient outcomes, is moving out of its native Sweden. We look at its business model and expansion plans. 
September 27, 2017

Interview: Zeeshan Syed, CEO at start up Health(at)Scale, on big data now and in 3-5 years

Using AI and machine learning to interpret big data promises to cut fraud, cut costs, deliver massive system improvements and improve diagnosis. Worldwide, there are probably over a thousand IT companies seeking to use big data to improve healthcare outcomes, ranging from Dr Watson, Microsoft, Google, Siemens, Philips and GE through to a myriad of start ups.
July 5, 2017

FREE BLOG What do you do when medical professionals go off the tracks?

Every year, some 12,000 medical and care professionals are subject to serious investigation by the three largest professional bodies in the UK alone. So how do you deal with the doctor or nurse who starts abusing colleagues, who has sex with a patient, who makes mistakes or lies on their CV? We talk to Jonathan Coe, who runs The Clinic for Boundaries Studies, which offers an intensive course to get perpetrators to open their eyes, take responsibility and change their behaviour.
June 8, 2017

GenesisCare consolidates Spanish oncology

Australian radiotherapy group GenesisCare is buying a 100% stake in Spain's second largest cancer group Oncosur. It will integrate with market leader IMOncology, which Genesis bought in June this year.
September 20, 2016

Auna’s frenetic race to build national chain in Peru

Private equity-backed Auna has gone from oncological payor-provider to Peru's third largest private healthcare chain in just three years. We speak to financial analyst Fernando Adrián Mendoza at Auna to get a grasp of Peru's prompt healthcare transformation. With global operators like Bupa lurking within Latin America, it's only a matter of time before M&A heats up in this country of 31m.
July 29, 2016

China Resources to buy GenesisCare

Macquarie-backed, state-owned conglomerate China Resources (CR) is waiting for Australian regulatory approval to buy private equity house KKR's 45% stake in oncology group GenesisCare. CR wants to continue expanding Genesis in Western Europe and to tap the Chinese market with new hospital management contracts. The deal values the company at US$1.3bn.
July 26, 2016

Carlyle to exit Concord

Private equity house Carlyle is exiting Chinese outsourcing group Concord Medical Services as management delists the company from the New York Stock Exchange. CEO Jianyu Yang's investment vehicle Morgancreek Investment and partner Blue Ocean Management will gain full ownership. They plan to expand the business to wholly owned cancer centres.
July 20, 2016
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us